Skip to main content

HyOrc Corporation Secures Financing for Initial Module of 35 TPD Portuguese Waste-to-Methanol Facility

HOUSTON, June 15, 2026 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCQB: HYOR) today announced it has secured financing for the first module of its 8 Tonnes Per Day (TPD) commercial waste-to-methanol facility in Porto, Portugal. Manufacturing is actively underway for an initial modular unit capable of producing up to 1 TPD of green methanol, targeted for shipment in September 2026. This milestone accelerates HyOrc’s mission to provide decentralized, sovereign energy security. As industrialized nations remain exposed to volatile global supply chains, HyOrc unlocks a massive domestic reserve: legacy Refuse-Derived Fuel (RDF). By converting local waste into competitive green methanol, the company turns an environmental liability into a home-grown strategic fuel. The Porto deployment builds on HyOrc’s proven operational track record, which...

Continue reading

Core AI Holdings Appoints John Clinton Haley Former Meta Leader to Advisory Board

AI Infrastructure leader and Allianca Group CEO brings deep data center development expertise to support Core’s AI infrastructure strategy  MIAMI, FL, June 15, 2026 (GLOBE NEWSWIRE) — Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI”), a global AI technology and infrastructure company, today announced the appointment of John Clinton Haley, Co-Founder and Chief Executive Officer of Allianca Group Inc., to its Advisory Board. Haley joins Core AI following the Company’s recently announced strategic joint venture with Allianca, a partnership designed to accelerate the development and delivery of AI-ready data center infrastructure to meet rapidly growing demand for next-generation compute capacity. As Co-Founder and CEO of Allianca Group, Haley has helped oversee the delivery of more than 720 MW of mission-critical...

Continue reading

Auction result of Treasury Bills – RIKV 26 0916 – RIKV 26 1216

Series  RIKV 26 0916 RIKV 26 1216Settlement Date  06/18/2026 06/18/2026Total Amount Allocated (MM)  19,706 18,370All Bids Awarded At (Price / Simple interest)  98.044 / 7.980 96.110 / 8.050Total Number of Bids Received  13 15Total Amount of All Bids Received (MM)  21,706 24,370Total Number of Successful Bids  11 12Number of Bids Allocated in Full  11 12Lowest Price / Highest Simple Interest Allocated  98.044 / 7.980 96.110 / 8.050Highest Price / Lowest Simple Interest Allocated  98.111 / 7.701 96.301 / 7.640Lowest Price / Highest Simple Interest Allocated in Full  98.044 / 7.980 96.110 / 8.050Weighted Average of Successful Bids (Price/Simple Interest)  98.075 / 7.851 96.185 / 7.889Best Bid (Price / Simple Interest)  98.111 / 7.701 96.301 / 7.640Worst Bid (Price / Simple Interest)  98.030 / 8.038 96.068 / 8.141Weighted...

Continue reading

Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview

Company’s Founder Details Production Growth, Industry Transformation Strategy, and Expanding Commercial Opportunities for Recombinant Spider SilkKim ThompsonKim Thompson, Founder and CEO of Kraig Biocraft LaboratoriesANN ARBOR, Mich., June 15, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that Founder and Chief Executive Officer Kim Thompson was recently featured in an extensive interview with Pulse 2.0, where he discussed the Company’s technological leadership, commercial production progress, expanding market opportunities, and long-term vision for transforming the global advanced materials industry. The interview comes as Kraig Labs continues...

Continue reading

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

–Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Neurology Product– –Seventh Addition to Lifecore’s Late-Stage Pipeline in Seven Months– CHASKA, Minn., June 15, 2026 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced it has signed a new agreement with a global pharmaceutical company. Under the terms of the agreement, Lifecore will perform technical transfer services to support the commercial production of an injectable suspension product for neurological disorders.    “With this significant new customer win, we have secured our seventh agreement for a late-stage program within the last seven months, reflecting how our focused business development...

Continue reading

Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026

Results from prespecified assessment of End of Progression™ in the RAPIDe-3 Phase 3 study and clinical relevance of this newly-defined endpoint detailed in an oral presentation Evidence on the cardiovascular safety profile of deucrictibant in clinical studies to date presentedZUG, Switzerland, June 15, 2026 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated angioedema, such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), summarized the presentations from the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2026, which took place from June 12-15, 2026, in Istanbul, Turkey. “The data presented...

Continue reading

Genco Shipping & Trading Limited Urges Shareholders to Vote “FOR” its Highly Qualified Directors at June 18th Annual Meeting

Leading Proxy Advisory Firms – ISS, Glass Lewis and Egan-Jones – All Support Reelection of Genco’s Full Board, Who Continue to Deliver Superior Shareholder Value in a Strengthening Drybulk Market Diana’s Handpicked Nominees Pose Significant Risks to Shareholders’ Investments   Additional Information and Video on How to Vote the WHITE Proxy Card is Available at www.GencoDrivesSuperiorReturns.com NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today issued the following reminder to all Genco shareholders ahead of the Company’s Annual Meeting of Shareholders scheduled for June 18, 2026:Genco’s Annual Meeting is this week and time is running out.       We...

Continue reading

Castellum Joint Venture Wins Position on $250 Million U.S. Navy Logistics IT Multiple Award Contract

VIENNA, Va., June 15, 2026 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (“Castellum” “CTM”, or the “Company”), a cybersecurity, electronic warfare, and software services company focused on the federal government, announced today that its joint venture CTM JV, LLC has been awarded a contract to the Logistics IT Integration and Support (“LIIS”) Capability Modernization, Deployment, and Support (“CMDS”) Multiple Award Contract (“MAC”). The MAC is structured as an indefinite delivery/indefinite quantity (“IDIQ”) contract vehicle, under which the United States Navy will competitively award individual task orders for specific projects, with a total maximum value of approximately $250 million. The LIIS CMDS MAC is designed to address the need for a full range of Logistics Information Technology (“LOG IT”) requirements by providing...

Continue reading

Akamai Unveils Agentic Security Framework to Power Trusted AI-Driven Interactions and Commerce

Unified framework secures and scales interactions across the emerging AI-driven economy Know Your Agent protocol verifies identity and human attribution by linking AI agents to authorized human users Real-time decisioning layer connects identity and behavior to automate secure digital commerce Distributed edge enforcement protects performance while validating every automated request Enhanced visibility allows organizations to distinguish, manage, and monetize agentic trafficCAMBRIDGE, Mass., June 15, 2026 (GLOBE NEWSWIRE) — As AI agents increasingly act on behalf of users, every request raises critical questions of identity, intent, and trust. To address this, Akamai (NASDAQ: AKAM) today announced its unified agentic framework for its Bot & Agent Control solutions, which connects identity, observability, trust, and edge...

Continue reading

Final terms for bonds admitted to trading 17th June 2026

To Nasdaq Copenhagen A/S                                                               15 June 2026 Announcement no. 51/2026 Final terms for bonds admitted to trading 17th June 2026 On 17th June 2026, Jyske Realkredit A/S will be admitted to trading new Covered Bonds (SDO). Final terms for the bond are attached to this announcement. The full prospectus for the Bonds consists of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated June 4th 2026. Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.com Yours sincerely, Jyske Realkredit Please observe that the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.